AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03366272 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Oxaliplatin
Description: eight cycles of (R)-GemOx in 2-wk intervals
Study NCT03366272 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: eight cycles of (R)-GemOx in 2-wk intervals
Study NCT04075292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acalabrutinib
Description: acalabrutinib 100 mg twice daily orally
Study NCT04075292 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rituximab
Description: Rituximab: 375 mg/m2 IV infusion on Day 1 of Cycle 1. 500 mg/m2 IV infusion on Day 1 for each of subsequent cycles (Cycles 2-6)
Study NCT04075292 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chlorambucil
Description: Chlorambucil: 0.5 mg/kg body weight orally on Day 1 and Day 15 of Cycles 1-6
Study NCT02414477 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Deuterated NNN
Description: Smokeless tobacco study product
Study NCT03363087 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mapping
Description: Omnipolar mapping of left atrial scar and pulmonary vein isolation lines
Study NCT02034682 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Volulyte 6%
Description: During elective coronary artery bypass grafting surgery, patients need to be attached to a cardiopulmonary bypass circuit. Administration of Volulyte 6% to the cardiopulmonary bypass circuit.
Study NCT02034682 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Geloplasma
Description: During elective coronary artery bypass grafting surgery, patients need to be attached to a cardiopulmonary bypass circuit. Administration of Geloplasma to the cardiopulmonary bypass circuit.
Study NCT00857831 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D and Calcium
Description: 2000 IU/day Vitamin D3 (cholecalciferol) and 1.3 g/day calcium carbonate will be taken for 15-20 weeks.
Study NCT03871010 — intervention group
Intervention type: DEVICE
Intervention: Midline catheter
Description: Midline catheter is used for administration of intravenous therapy, and is inserted in a larger vein.
Study NCT04595435 — intervention group
Intervention type: PROCEDURE
Intervention: Lumpectomy
Description: Removal of lump/tumor from breast utilizing an approach that saves as much breast as possible.
Study NCT04595435 — intervention group
Intervention type: RADIATION
Intervention: Intraoperative Radiation Therapy
Description: Delivery of low energy radiation therapy directly at surgical site, immediately removal of lump and tissue prior to final surgical closure
Study NCT03485287 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midomafetamine HCl
Description: Three sessions of MDMA-assisted therapy with flexible dose of midomafetamine HCl from 100 to 125 mg and optional supplemental dose half that of initial dose 1.5 to 2 hours later
Study NCT04280029 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SELUTION SLR™ DEB
Description: The SELUTION Sustained Limus Release (SLR)™ drug-eluting balloon (DEB) catheter is a combination product consisting of a standard percutaneous transluminal coronary angioplasty (PTCA) balloon catheter coated with a drug (Sirolimus).
Study NCT04280029 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: POBA or FDA-approved -limus DES
Study NCT02116335 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bosentan
Description: Stress response and vascular function will be assessed 3 days following 125 mg twice per day of Bosentan
Study NCT02116335 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Stress response and vascular function will be assessed 3 days following twice per day placebo
Study NCT03485287 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Manualized therapy
Description: Non-directive therapy
Study NCT05577624 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AMG 510
Description: Oral tablet
Study NCT05577624 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifampin
Description: Oral capsule
Study NCT00499330 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: lobectomy
Study NCT00499330 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: segmentectomy or wedge resection
Study NCT03779984 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Red Rubber Catheter
Description: Experimental group will be intubated with red rubber catheter guidance
Study NCT03779984 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Standard nasal tracheal Intubation
Description: Control group will be intubated with standard nasal tracheal tube without guidance
Study NCT03289039 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neratinib
Description: Neratinib is a recently discovered oral drug that may stop breast cancer cells from growing abnormally by inhibiting (or blocking) members of a family of proteins that include Human Epidermal Growth Factor Receptor 2 (HER2)
Study NCT03289039 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fulvestrant
Description: Fulvestrant, works in treating breast cancer that has spread to other parts of the body
Study NCT06454825 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous drug
Description: medications were applied intravenously to the groups 30 minutes before end of the procedure
Study NCT04094519 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: enzalutamide
Description: oral
Study NCT04094519 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: enzalutamide Placebo
Description: oral
Study NCT04094519 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: digoxin
Description: oral
Study NCT04094519 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rosuvastatin
Description: oral
Study NCT06215547 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Enterra HDE
Description: Instructions for use Implanting physicians should have experience in the surgical and/or implantation techniques for the Enterra II system, operational and functional characteristics of the Enterra II system, 12 English 37800 2014-03 and experience in the continued management of patients by stimulation parameter adjustment. Physicians may contact Medtronic before prescribing or implanting an Enterra II system for the first time, and request a referral to a physician experienced in the use of the Enterra II system. Implanting physicians should be thoroughly familiar with all product labeling.~Cautions:~* When using sharp instruments near the neurostimulator, be extremely careful to avoid nicking or damaging the case, the insulation, or the connector block. Damaging the neurostimulator may require surgical replacement.~* Do not use saline or other ionic fluids at connections, which could result in a short circuit
Study NCT02972034 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-8353
Description: PO capsule
Study NCT03779724 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: exercises
Study NCT03779724 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercises
Study NCT02886520 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PVDF transobturator tape
Study NCT02886520 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Polypropylene transobturator tape
Study NCT03266094 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: BiZact™: A bipolar instrument for tonsillectomies
Description: A bipolar electrosurgical device that employs RF energy and pressure to ligate vessels interposed between its jaws which can then be transected using the built in knife deployed by the device trigger.
Study NCT03548909 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: VITROS Immunodiagnostic Products
Description: NT-proBNP II assay
Study NCT01448278 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: All-inside
Description: The All-inside technique is a new minimally invasive procedure for anterior cruciate ligament reconstruction (ACL). It consists of incomplete bone tunnels drilling and cortical fixation.
Study NCT01448278 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Classical technique
Description: The Classical technique is a usual procedure for anterior cruciate ligament reconstruction (ACL). The fixation is achieved with interference screws.
Study NCT01850524 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ixazomib
Description: IXAZOMIB capsules.
Study NCT01850524 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: IXAZOMIB matching-placebo capsules.
Study NCT02972034 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: IV infusion
Study NCT06454825 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous drug
Description: medications were applied intravenously to the groups 30 minutes before end of the procedure
Study NCT04126070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Androgen Deprivation Therapy
Description: Given per standard care for duration of study. Regimens include Leuprolide (Lupron Depot) intramuscularly every 3 months, Goserelin acetate (Zoladex) subcutaneously every 4 weeks, or degarelix (Firmagon) subcutaneously every month per standard of care.
Study NCT01696019 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fast walking
Description: Participants assigned to this group met with two group leaders three times per week in the morning in Jing An Park and were encouraged to walk quickly around a 400 meter circular route. Each session consisted of 10 minutes of warm-up stretching, 30 minutes of brisk walking, and 10 minutes of cool-down exercises. Prior to the first session, each participant was given a pedometer with their name on it. They were asked to take 100 steps and the sensitivity and positioning of the pedometer was adjusted to assure accurate measurement. At the termination of each session, the pedometers were collected and the number of steps taken by each participant at that session recorded. A record of the number of steps taken for every participant at each session over the 40 week period was maintained.
Study NCT04126070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Given once per every 3 weeks for cycle 1-6 intravenously and then every 4 weeks during subsequent cycles, at predetermined dosage; up to 28 cycles total.
Study NCT04126070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: Given once every 3 weeks intravenously at pre determined dosage for cycle 1-6.
Study NCT01696019 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Tai Chi
Description: Participants assigned to this group met with a Tai Chi master and assistant three times per week in the morning in Jing An Park or at a nearby gymnasium depending on weather conditions. Each session included 20 min of warm-up exercises (lower back and hamstring stretching, gentle calisthenics, and balance training), 20 min of Tai Chi practice, and 10 min of cool-down exercises.
Study NCT01696019 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intellectual stimulation
Description: Participants assigned to this group met with a group leader and an assistant for one hour three times a week in the morning at the neighborhood community center. Although direction was initially given regarding subjects for discussion, the participants decided on their own to organize and select topics themselves.
Study NCT01696019 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Contact and testing only
Study NCT00006003 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: semaxanib
Description: Given IV
Study NCT00006003 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT04261725 — intervention group
Intervention type: GENETIC
Intervention: EGFR mutation
Description: Searching the EGFR mutation in pulmonary biopsy
Study NCT05321758 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Fecal Microbiota Transplantation
Description: In the induction stage of CD, FMT was given 1-3 courses, 3-6 times per course.
Study NCT05321758 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Immunosuppressive Agents
Description: hormones, azathioprine, thalidomide
Study NCT02552745 — intervention group
Intervention type: DRUG
Intervention: parecoxib sodium
Description: parecoxib sodium was administered postoperatively, when transcatheter arterial embolization finished.
Study NCT02070419 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: transarterial chemoembolization
Description: Undergo TACE with doxorubicin-eluting beads
Study NCT02070419 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: transarterial chemoembolization
Description: Undergo TACE with doxorubicin-eluting beads
Study NCT02070419 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: stereotactic radiosurgery
Description: Undergo SBRT
Study NCT04607213 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Advancement-rotation approach based on Millard' for repairing lip defect.
Description: patients were treated using Millard technique is the downward rotation of the medial part of the flap, and lateral advancement of the flap to close and fill the defect. if more lip height is needed; cut- as- you-go by adding a back-cut incision at the end of his rotation incision down toward the philtral ridge of non-clefted side. Moreover; C-flap is used to close nasal sill.
Study NCT04607213 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Straight-line approach
Description: patients were treated using Straight-Line design based on Fisher modification. C-shaped flap extend from the proposed nasal sill to the origin of philtral column of medial flap as a straight incision to the planned top of the cupid's bow. In addition, to the previous mentioned incision, small inlate incision is needed to length the cleft side on the medial flap.~On the other hand, on the lateral flap; two connected triangular incisions are used; one on the vermillion border at Noordhoff's point. And the other one just above the cutaneous margin to improve aesthetic outcome and diminish formed scar.
Study NCT00494650 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT)
Description: CBT will include 12 to 16 counseling sessions, occurring weekly or every other week. Participants will learn about PTSD and ways to decrease anxiety associated with PTSD by completing homework assignments and practicing skills learned in counseling sessions.
Study NCT00494650 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Brief PTSD treatment
Description: Brief PTSD treatment will include three weekly meetings with a therapist. Participants will learn about PTSD, how symptoms may be affecting their lives, and a technique for reducing anxiety associated with PTSD.
Study NCT02438384 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video
Description: This is a 10 minute interactive video which provided information to the viewer regarding the safe and effective use of analgesics for acute musculoskeletal pain at home. The focus is on acetaminophen, NSAIDs, and opioids.
Study NCT02438384 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Phone follow-up
Description: The call will be made by the study coordinator, who is a medical student. Any patients reporting a pain score in the past 24 hours of 4 or more will be re-contacted by an emergency physician with special training in geriatric pain management. This individual will provide recommendations to the patient regarding treatment options.
Study NCT03143907 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Mindfulness Ambassador Council for Early Psychosis (MAC-EP)
Description: MAC is a 12-week facilitated group mindfulness intervention promoting the development of social-emotional competence in youth created by Mindfulness Without Borders (MWB; www.mwb.org). A meditative practice, mindfulness focuses one's awareness on the present, acknowledging and accepting without judging one's feelings, thoughts, or bodily sensations. Each session has a unique focus (e.g., paying attention, practicing gratitude) and consists of facilitated group learning, discussion and mindfulness skills practice. Home assignments to help reinforce specific lesson are also assigned. MAC has demonstrated acceptability, feasibility, and promising beneficial effects in schools, and in the pilot study conducted at the Early Psychosis Program at London Health Sciences Centre in London, Ontario. Its youth-focus and emphasis on building social and emotional competencies through mindfulness make it a promising intervention for youth recovering from their first episode of psychosis.
Study NCT02889289 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Xbox One Kinect Gaming
Description: The Veteran completed 15 sessions of supervised VR training. Each session lasted between 50 and 60 minutes in total. The intervention utilized 2 commercially available Xbox One Kinect games called Shape Up and Kinect Sports: Rivals to challenge both cardiovascular and balance systems. Each game is composed of mini-games (MG). Each MG lasted between 1:30 minutes to 4:00 minutes. Both games were played for approximately 25 minutes during each session. Rest breaks were allowed as the participant required them. Guarding by a therapist was provided dependent on the challenge of the game and the participant's abilities.
Study NCT00771043 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TYSABRI and AVONEX
Description: TYSABRI and AVONEX treatment per package insert.
Study NCT04065074 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FX006 32 mg
Description: Extended-release 32 mg FX006 IA injection
Study NCT03345160 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peanut Flour
Description: open label oral immunotherapy
Study NCT01103154 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: carvedilol
Description: 6.25mg per day, increase to 6.25mg bid
Study NCT01103154 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: nadolol + ISMN
Description: nadolol 40-80mg ISMN 10-20mg
Study NCT01521871 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Skin wound closure by tissue glue
Description: The glue is used both as closure device and as wound dressing.
Study NCT01521871 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Skin wound closure by conventional suture + dressing
Description: Suture: Intracutaneous skin closure, by running, absorbable suture (Caprosyn 4-0) Dressing: Conventional textile dressing (Mepor)
Study NCT00948857 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dehydroepiandrosterone
Description: 25 mg PO TID
Study NCT00948857 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Blinded placebo
Study NCT04200196 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: fabrique à histoire
Description: Fabrique à histoire is a participatory entertainment method. Children of this arm going to create and listening a story before and during the venous puncture.
Study NCT04200196 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: It is a passive entertainment method. Children of this arm going to do habitual activities before and during the venous puncture, like to sing, blow up a balloon, to play with recreational thing, etc.
Study NCT03419897 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Administered intravenously
Study NCT04511871 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CCT303-406
Description: Blood will be collected from subjects to isolate peripheral blood mononuclear cells for the production of CCT303-406. Subjects will receive the conditioning chemotherapy regimen of cyclophosphamide and fludarabine for lymphodepletion followed by a single dose of CCT303-406 via intravenous injection.
Study NCT02617407 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Livionex® Dental Gel
Description: Oral application Dental Plaque, Gingivitis and Oral Microbiome Control.
Study NCT02617407 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PreviDent 5000 plus/Tom's of Maine Children's toothpaste
Description: Oral application for Dental Plaque, Gingivitis and Oral Microbiome Control.
Study NCT02617407 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Kolibree Toothbrush
Description: Electric Toothbrush
Study NCT02617407 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Kolibree Toothbrush
Description: Electric Toothbrush
Study NCT03300141 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Veridical Visual Feedback
Description: Reaching while sitting at the Looking Glass system. The representation of arm movements will directly reflect the participants actual arm movements.
Study NCT03300141 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Augmented Visual Feedback
Description: Reaching while sitting at the Looking Glass system. The representation of a participant's arm movements will be augmented to encourage different movement patterns and improved movement.
Study NCT03300141 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Healthy Comparative Reaching Task
Description: Reaching while sitting at the Looking Glass system. This will occur over the course of 1 hour.
Study NCT02652585 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Naltrexone
Study NCT02652585 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: capsule filled with micro crystalline cellulose, manufactured to mimic naltrexone capsule